Literature DB >> 25264988

Vascular Dysfunction in Diabetes and Glaucoma: A Complex Relationship Reviewed.

Austin L Gerber1, Alon Harris, Brent Siesky, Eric Lee, Tara J Schaab, Andrew Huck, Annahita Amireskandari.   

Abstract

Open-angle glaucoma (OAG) is a multifactorial disease characterized by progressive retinal ganglion cell death and visual field loss. Intraocular pressure, ocular perfusion pressure, and systemic vascular irregularities have all been identified as contributing factors for glaucoma onset and progression. Focal and systemic vascular abnormalities have also been well documented in diabetic patients. The relationship between diabetes mellitus and OAG remains enigmatic in the literature. As the pathogenesis of both diabetes mellitus and OAG involves compromised vascular regulation, this review was undertaken to further investigate their precise relationship. A literature review of published population-based studies was performed, with a focus on studies regarding blood flow abnormalities. Although current studies support the role of vascular contributions to both diseases, the association between glaucoma and diabetes yields contrasting results.

Entities:  

Mesh:

Year:  2015        PMID: 25264988     DOI: 10.1097/IJG.0000000000000137

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  12 in total

Review 1.  Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities.

Authors:  Kimberly A Fernandes; Jeffrey M Harder; Pete A Williams; Rebecca L Rausch; Amy E Kiernan; K Saidas Nair; Michael G Anderson; Simon W M John; Gareth R Howell; Richard T Libby
Journal:  Exp Eye Res       Date:  2015-06-24       Impact factor: 3.467

2.  The role of big data analysis in identifying a relationship between glaucoma and diabetes mellitus.

Authors:  Ein Oh; Yong Hyun Kim; Ik Hee Ryu; Tae Keun Yoo
Journal:  Ann Transl Med       Date:  2022-09

3.  Ocular blood flow as a clinical observation: Value, limitations and data analysis.

Authors:  Alon Harris; Giovanna Guidoboni; Brent Siesky; Sunu Mathew; Alice C Verticchio Vercellin; Lucas Rowe; Julia Arciero
Journal:  Prog Retin Eye Res       Date:  2020-01-24       Impact factor: 21.198

4.  Analysis of the influence of type of diabetes mellitus on the development and type of glaucoma.

Authors:  Emina Alimanovic Halilovic; Sanida Ljaljevic; Ilda Alimanovic; Milka Mavija; Ana Oros; Faruk Nisic
Journal:  Med Arch       Date:  2015-02-21

5.  The genetics of POAG in black South Africans: a candidate gene association study.

Authors:  Susan E I Williams; Trevor R Carmichael; R Rand Allingham; Michael Hauser; Michele Ramsay
Journal:  Sci Rep       Date:  2015-02-11       Impact factor: 4.379

Review 6.  The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration.

Authors:  Marita Pietrucha-Dutczak; Marialaura Amadio; Stefano Govoni; Joanna Lewin-Kowalik; Adrian Smedowski
Journal:  Front Neurosci       Date:  2018-11-15       Impact factor: 4.677

Review 7.  Therapeutic Ophthalmic Lenses: A Review.

Authors:  N Toffoletto; B Saramago; A P Serro
Journal:  Pharmaceutics       Date:  2020-12-28       Impact factor: 6.321

Review 8.  Oxidative Stress and the Role of NADPH Oxidase in Glaucoma.

Authors:  Jennifer C Fan Gaskin; Manisha H Shah; Elsa C Chan
Journal:  Antioxidants (Basel)       Date:  2021-02-04

9.  Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications.

Authors:  Aditya Belamkar; Alon Harris; Ryan Zukerman; Brent Siesky; Francesco Oddone; Alice Verticchio Vercellin; Thomas A Ciulla
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

Review 10.  Prevalence Rates and Risk Factors for Primary Open Angle Glaucoma in the Middle East.

Authors:  Rana Torabi; Alon Harris; Brent Siesky; Ryan Zukerman; Francesco Oddone; Sunu Mathew; Ingrida Januleviciene; Alice C Verticchio Vercellin
Journal:  J Ophthalmic Vis Res       Date:  2021-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.